Navigation Links
Stereotyping prime obstacle to women in commercial science
Date:3/12/2013

COLLEGE PARK, Md. - Female professors are almost 50 percent less likely than their male counterparts to be invited to join corporate scientific advisory boards (SABs) and start new companies mainly because of gender stereotyping, says University of Maryland researcher Waverly Ding, an assistant professor of management at the Robert H. Smith School of Business.

Beliefs that women lack leadership and business savvy, and are not capable of helping new ventures attract investment, block their advancement in these areas, she says.

Ding, with co-authors Fiona Murray of MIT and Toby E. Stuart of University of California Berkley, draw this conclusion from survey data and related statistics from the biotech industry and 6,000 U.S. scientists whose careers span 30-plus years. The study, "From Bench to Board: Gender Differences in University Scientists' Participation in Corporate Scientific Advisory Boards," appears in a recent issue of Academy of Management Journal.

The study controlled for the scientists' professional accomplishments, social networks, employer characteristics and proxies for subject interest in commercial science.

"Women are available," says UMD's Ding. "The numbers are there. They just are not being selected." In the data sample's final year (2002), women comprised about 30 percent of about 6,000 PhDs from U.S. universities or research institutions, but just 7 percent (49 of 720) of those scientists served on SABs of 511 U.S. biotech firms. She says this percentage never exceeded 10.2 during the study's 1972-2002 window.

Though her data appears to be the latest available that's specific to the SAB gender breakdown in the biotech industry, Ding says she suspects the percentage of female SAB members serving biotech firms falls below the overall, 12.6-percentage of women on U.S. corporate boards in 2012 (according to an independent study: http://info.gmiratings.com/gmi-ratings-2012-women-on-boards-survey/).

But, she says, academia can effectively counteract the inequity.

"University scientists have helped create at least half of the publicly traded biotech firms operating today, and our data shows a female professor is most likely to draw a science advisory board invitation by tapping into her school's technology transfer office," says Ding. "Biotechnology founders strongly gauge an SAB candidate's reputation and quality of his or her network in determining that individual's business savvy."

But not all institutions formally support such offices even though they "provide an ideal means for academic administrators to raise the profile of their high-performing female scientists," she says. "Networking by way of technology-transfer offices can be useful in promoting the research of women faculty and brokering connections between them and influential members of the entrepreneurship and investment communities."

She concludes the influence factor is a major issue, since gender bias appears most active in high-profile companies backed by high-status venture capitalists. "When female scientists do receive invitations to join boards, they generally come from small start-ups with limited financial backing."

Further measuring the effects of specific areas of research interest and individual career aspiration on the SAB gender gap can deepen the understanding this issue and help erode gender inequity more broadly at the corporate leadership level, says Ding. "Our nation's continued preeminence in science and technology will depend on engaging the best and the brightest, regardless of gender."


'/>"/>

Contact: Greg Muraski
gmuraski@rhsmith.umd.edu
301-892-0973
University of Maryland
Source:Eurekalert

Related biology news :

1. Winners of the 2012 F1000Prime Faculty Member of the Year Awards
2. Marginal lands are prime fuel source for alternative energy
3. Study identifies prime source of ocean methane
4. Computer model pinpoints prime materials for efficient carbon capture
5. New book celebrates women scientists in the Americas
6. Progesterone may be why pregnant women are more vulnerable to certain infections
7. Genetic signs of alcoholism in women studied for the first time
8. African-American, Caucasian women should take identical vitamin D doses
9. Cancer risk for African-American women with benign breast disease factors Wayne State finds
10. Few pregnant women treated for sexually transmitted infections
11. Geneviève Almouzni to receive the 2013 FEBS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
Breaking Biology Technology: